Processa Pharmaceuticals Inc
(NAS:PCSA)
$
1.7606
0.0306 (1.77%)
Market Cap: 5.03 Mil
Enterprise Value: -3.84 Mil
PE Ratio: 0
PB Ratio: 0.57
GF Score: 30/100 Processa Pharmaceuticals Inc (PCSA) Transcripts
- Processa Pharmaceuticals Inc at EBD Group Biotech Showcase TranscriptJan 09, 2024
- Processa Pharmaceuticals Inc Fireside Chat TranscriptDec 20, 2023
- Processa Pharmaceuticals Inc at ThinkEquity Conference TranscriptOct 19, 2023
- Q4 2022 Processa Pharmaceuticals Inc Earnings Call TranscriptMar 30, 2023$9.6 (+5.63%)Earnings
- Processa Pharmaceuticals Inc at EBD Group Biotech Showcase TranscriptJan 11, 2023
- Q3 2022 Processa Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2022$43 (+1.90%)Earnings
- Processa Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 14, 2022
- Q2 2022 Processa Pharmaceuticals Inc Earnings Call TranscriptAug 11, 2022$62.9 (-2.78%)Earnings
- Q1 2022 Processa Pharmaceuticals Inc Earnings Call TranscriptMay 12, 2022$39 (+8.94%)Earnings
- Q3 2021 Processa Pharmaceuticals Inc Earnings Call TranscriptNov 11, 2021$142.4 (+3.64%)Earnings
- Q2 2021 Processa Pharmaceuticals Inc Earnings Call TranscriptAug 12, 2021$117 (+1.39%)Earnings
- Q1 2021 Processa Pharmaceuticals Inc Earnings Call TranscriptMay 13, 2021$123.2 (-0.81%)Earnings
- Q3 2020 Processa Pharmaceuticals Inc Earnings Call TranscriptNov 12, 2020$84.2 (-0.94%)Earnings
- 1